medigraphic.com
Revista Médica Sinergia

2019, Number 03

<< Back Next >>

Revista Médica Sinergia 2019; 4 (03)

Retinopathy of prematurity

Cortés BF, Cortés MEI, Duarte ND, Quesada CJV

Language: Spanish
References: 27
Page: 38-49
PDF size: 286.75 Kb.


ABSTRACT

Retinopathy of prematurity continues to be the leading cause of childhood blindness that primarily affects premature and low birth weight babies. The prevention of preterm birth is the most effective strategy to reduce the incidence of retinopathy of prematurity. Timely identification and treatment are essential to prevent the unnecessary loss of vision caused by retinopathy of prematurity. It has been associated with multiple risk factors among the main low birth weight, gestational age and use of supplemental oxygen, among others. Its clinical picture is characterized by a retrolental membrane that causes leukocoria and eventually without treatment with potential complications such as glaucoma, cataract, myopia and blindness, the latter being the most serious. The current standard of treatment continues to be ablative therapy through laser photocoagulation of the peripheral avascular ischemic retina and studies are currently being conducted with anti VEGF which have shown significant benefits, however, they have not yet been approved by the FDA for its clinical use.


REFERENCES

  1. Lueder G, Archer, MD, S, Hered, MD, R, Karr D, Kodsi S. 2018-2019 BCSC (Basic and Clinical Science Course), Section 06: Pediatric Ophthalmology and Strabismus (MAJOR REVISION). 2017. San Francisco, CA: American Academy of Ophthalmology. Disponible en: https://www.aao.org/assets/5e0f04a7-77a1-457b-81af- 2f650333faae/636312517616000000/bcsc1718-s06-pdf

  2. Messa AA, Mattos RB, Areco KCN, Sallum JMF. Vision-related quality of life in children with retinopathy of prematurity. Arquivos Brasileiros de Oftalmologia. 2015;78(4):224-228. https://doi.org/10.5935/0004-2749.20150058

  3. Kliegman R, Stanton B, Geme J, Schor N. Nelson. Tratado de pediatría. 20ed.. Elsevier; 2016 06. Disponible en: https://tienda.elsevierhealth.com/nelson-tratado-de-pediatria-9788491130178.html

  4. Camba Longueira F, Perapoch López J, Martín Begué N. Retinopatía de la prematuridad. Protocolos Diagnóstico Terapeúticos de la AEP: Neonatología. 2008. Disponible en: https://www.aeped.es/sites/default/files/documentos/46.pdf

  5. Asano MK, Dray PB. Retinopathy of prematurity. Disease-a-Month. 2014 06;60(6):282-291. https://doi.org/10.1016/j.disamonth.2014.03.009

  6. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. The Lancet. 2013 Oct;382(9902):1445-1457. https://doi.org/10.1016/s0140-6736(13)60178-6

  7. Arnesen L, Durán P, Silva J, Brumana L. A multi-country, cross-sectional observational study of retinopathy of prematurity in Latin America and the Caribbean. Rev Panam Salud Publica. 2016;39(6):322–29. Disponible en: http://iris.paho.org/xmlui/handle/123456789/28539

  8. Gunn DJ, Cartwright DW, Gole GA. Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity. Clinical & Experimental Ophthalmology. 2014 01 23;42(5):459- 465. https://doi.org/10.1111/ceo.12280

  9. Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Survey of Ophthalmology. 2017 05;62(3):257-276. https://doi.org/10.1016/j.survophthal.2016.12.004

  10. Smith LE. Pathogenesis of retinopathy of prematurity. Seminars in Neonatology. 2003 Dec;8(6):469- 473. https://doi.org/10.1016/s1084-2756(03)00119-2

  11. Cayabyab R, Ramanathan R. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology. Neonatology. 2016 06 03;109(4):369-376. https://doi.org/10.1159/000444901

  12. Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Human Development. 2008 02;84(2):77-82. https://doi.org/10.1016/j.earlhumdev.2007.11.009

  13. Jordan CO. Retinopathy of Prematurity. Pediatric Clinics of North America. 2014 06;61(3):567-577. https://doi.org/10.1016/j.pcl.2014.03.003

  14. Good W, Hardy R, Dobson V, Palmer E, Phelps D, Quintos M, Tung B. The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study. PEDIATRICS. 2005 07 01;116(1):15-23. https://doi.org/10.1542/peds.2004-1413

  15. Quimson SK. Retinopathy of Prematurity: Pathogenesis and Current Treatment Options. Neonatal Network. 2015;34(5):284-287. https://doi.org/10.1891/0730-0832.34.5.284

  16. Isaza G, Donaldson L, Chaudhary V. Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre. Canadian Journal of Ophthalmology. 2018 07;. https://doi.org/10.1016/j.jcjo.2018.05.005

  17. Hartnett ME, Lane RH. Effects of oxygen on the development and severity of retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2013 06;17(3):229-234. https://doi.org/10.1016/j.jaapos.2012.12.155

  18. Saugstad OD. Oxygen and retinopathy of prematurity. Journal of Perinatology. 2006 04 25;26(S1):S46-S50. https://doi.org/10.1038/sj.jp.7211475

  19. Ortega-Molina JM, Anaya-Alaminos R, Uberos-Fernández J, Solans-Pérez de Larraya A, Chaves- Samaniego MJ, Salgado-Miranda A, Piñar-Molina R, Jerez-Calero A, García-Serrano JL. Genetic and Environmental Influences on Retinopathy of Prematurity. Mediators of Inflammation. 2015;2015:1-7. https://doi.org/10.1155/2015/764159

  20. Dai AI, Demiryürek S, Aksoy SN, Perk P, Saygili O, Güngör K. Maternal Iron Deficiency Anemia as a Risk Factor for the Development of Retinopathy of Prematurity. Pediatric Neurology. 2015 08;53(2):146-150. https://doi.org/10.1016/j.pediatrneurol.2015.04.002

  21. Zhou J, Shukla VV, John D, Chen C. Human Milk Feeding as a Protective Factor for Retinopathy of Prematurity: A Meta-analysis. PEDIATRICS. 2015 Nov 16;136(6):e1576-e1586. https://doi.org/10.1542/peds.2015-2372

  22. Chawla D, Agarwal R, Deorari A, Paul VK, Chandra P, Azad RV. Retinopathy of Prematurity. The Indian Journal of Pediatrics. 2010 Oct 27;79(4):501-509. https://doi.org/10.1007/s12098-010-0279-7

  23. Stahl A, Göpel W. Screening and Treatment in Retinopathy of Prematurity. Deutsches Aerzteblatt Online. 2015 Oct 23;. https://doi.org/10.3238/arztebl.2015.0730

  24. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280104/

  25. Casteels I, Cassiman C, Van Calster J, Allegaert K. Educational paper. European Journal of Pediatrics. 2011 Nov 04;171(6):887-893. https://doi.org/10.1007/s00431-011-1610-7

  26. Fierson W, Saunders R, Good W, Palmer E, Phelps D, Reynolds J, Chiang M. Screening Examination of Premature Infants for Retinopathy of Prematurity. PEDIATRICS. 2012 Dec 31;131(1):189-195. https://doi.org/10.1542/peds.2012-2996

  27. Sternberg P, Durrani AK. Evolving Concepts in the Management of Retinopathy of Prematurity. American Journal of Ophthalmology. 2018 02;186:xxiii-xxxii. https://doi.org/10.1016/j.ajo.2017.10.027




2020     |     www.medigraphic.com